Answer:
Annual increase is $1,108.4
Explanation:
In 2016, average price was $27,258.6
In 2010, average price was $20,608
Average increase in 6 years = $27,258.6 - $20,608 = $6,650.6
Annual average increase = $6650.6/6 = $1,108.4
Answer:
7.83%
Explanation:
This is calculated by using the Gordon growth model (GGM) formula as follows: P = d / (r - g) ……………………………………… (1)
Where;
P = market price of the stock = $24.09
d = next year annual dividend = $1.26 r = cost of equity = ?
g = dividend growth rate = 2.6%, or 0.026
Substituting the values into equation and solve for r, we have:
24.09 = 1.26 / (r - 0.026)
24.09 (r - 0.026) = 1.26
24.09r - 0.62634 = 1.26
24.09r = 1.26 + 0.62634
24.09r = 1.88634
r = 1.88634 / 24.09
r = 0.0783038605230386, or 7.83038605230386%
Rounding to 2 decimal places. we have:
r = 7.83%
Therefore, the correct option is 7.83 percent.
Answer:
Pharma One
The statement that indicates that KleenKare is a cash cow according to the the Boston Consulting Group (BCG) matrix is:
2. The demand for analgesic drugs in the Syrian market is expected to maintain a low-growth, high-share status.
Explanation:
A cash cow depicts the BCG matrix quadrant where there are higher returns, high market share in a low-growth market. The cash cow requires little investment to generate high returns. It also provides the cash for financing the other quadrants (dogs, stars, and question marks). Basically, the BCG matrix, also known as the Growth/Share Matrix, depicts the products' growth opportunities.
Answer:
ending work in process and the cost of units transferred out.
Explanation:
In a cost reconciliation schedule, costs accounted for is computed by adding the cost of the ending work in process and the cost of units transferred out.
The cost reconciliation schedule gives the relationship between total costs accounted for and total costs to be accounted for.
When the total costs accounted for equal the total costs to be accounted for, this is a cost reconciliation schedule.
